Related Experiment Video
Updated: Jul 16, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Horizons in pharmacologic intervention in allergic contact dermatitis
1Department of Dermatology, School of Medicine, University of California, San Francisco.
Journal of the American Academy of Dermatology
|December 1, 1994
Summary
Allergic contact dermatitis treatment is challenging. New therapies like tacrolimus and pentoxifylline offer targeted approaches to manage this skin condition by suppressing immune responses.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Allergic contact dermatitis (ACD) presents significant therapeutic challenges.
- Current treatments rely on allergen avoidance and corticosteroids, which have limitations.
- Increasing environmental antigen exposure necessitates more selective treatment options for ACD.
Purpose of the Study:
- To review established and emerging therapeutic agents for allergic contact dermatitis.
- To explore the mechanisms of action for novel ACD treatments.
- To highlight advancements in targeting skin immune responses in ACD.
Main Methods:
- Review of scientific literature on ACD pathogenesis and treatment.
- Analysis of the mechanisms of action for corticosteroids, FK 506 (tacrolimus), pentoxifylline, and vitamin D3 derivatives.
- Focus on cellular and molecular events in delayed hypersensitivity reactions.
Main Results:
- Established therapies like corticosteroids manage ACD symptoms.
- Emerging agents such as FK 506 (tacrolimus), pentoxifylline, and vitamin D3 derivatives show potential for targeted ACD suppression.
- Understanding skin immune system advances enables novel therapeutic strategies.
Conclusions:
- Targeted therapies are crucial for managing allergic contact dermatitis effectively.
- Novel agents offer promising alternatives to corticosteroids for ACD treatment.
- Further research into the skin immune system will drive future ACD management strategies.
Related Concept Videos
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...